<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="other" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <front>
    <journal-meta>
      <journal-id journal-id-type="pmc">JRMS</journal-id>
      <journal-id journal-id-type="pubmed">J Res Med Sci</journal-id>
      <journal-id journal-id-type="publisher-id">Journal of Research in Medical Sciences</journal-id>
      <journal-title>Journal of Research in Medical Sciences</journal-title>
      <issn pub-type="ppub">1735-1995</issn>
	<issn pub-type="epub">1735-7136</issn>
      <publisher>
        <publisher-name>Medknow Publications Pvt Ltd</publisher-name>
	<publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">JRMS-18-510</article-id>
      <article-id pub-id-type="pmid">24250702</article-id>
      <article-categories>
	<subj-group subj-group-type="headings">
		<subject>SHORT COMMUNICATION</subject>
	</subj-group>
      </article-categories>
      <title-group>
        <article-title>Cholorhexidine, octenidine or povidone iodine for catheter related infections: A randomized controlled trial</article-title>
      </title-group>
	<contrib-group>
<contrib contrib-type="author">
<name><surname>Bilir</surname>
<given-names>Ayten</given-names></name>
<xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib>
<contrib contrib-type="author">
<name><surname>Yelken</surname>
<given-names>Birg&#x00FC;l</given-names></name>
<xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author">
<name><surname>Erkan</surname>
<given-names>Ayse</given-names></name>
<xref ref-type="aff" rid="aff3"/></contrib>
</contrib-group>
<aff id="aff1">Department of Anaesthesiology and Reanimation, Eskisehir Osmangazi University, Medical Faculty, 26100 Eskisehir, Turkey</aff><aff id="aff2">Department of Anaesthesiology and Reanimation, Eskisehir Osmangazi University, Medical Faculty, 26100 Eskisehir, Turkey</aff><aff id="aff3">Department of Anaesthesiology and Reanimation, Eskisehir Osmangazi University, Medical Faculty, 26100 Eskisehir, Turkey</aff>

      <author-notes>
	<corresp id="cor1"><bold>Address for correspondence:</bold>Ayten Bilir, Department of Anaesthesiology and Reanimation, Osmangazi University Medical Faculty, 26100, Eskisehir, Turkey <email xlink:href="aytbilir@yahoo.com">aytbilir@yahoo.com</email></corresp>

      </author-notes>
      <pub-date pub-type="ppub">
        <season>June</season>
        <year>2013</year>
      </pub-date>
      <volume>18</volume>
      <issue>6</issue>
      <fpage>510</fpage>
      <lpage>512</lpage>   
      
<history>
<date date-type="received"><day>5</day><month>1</month><year>2012</year></date>

<date date-type="rev-recd"><day>6</day><month>1</month><year>2013</year></date>
</history>

      <permissions>
        <copyright-statement>Copyright: &#x000a9; Journal of Research in Medical Sciences</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
      </permissions>
      <abstract><sec id="st1"><title>Background:</title><p> Protection of the catheter site by antimicrobial agents is one of the most important factors in the prevention of infection. Povidone iodine and chlorhexidine gluconate are the most common used agents for dressing. The purpose of this study was to compare the effects of povidone iodine, chlorhexidine gluconate and octenidine hydrochloride in preventing catheter related infections. <sec id="st1"><title>Materials and Methods:</title><p> Patients were randomized to receive; 4&#x0025; chlorhexidine gluconate, 10&#x0025; povidone iodine or octenidine hydrochlorodine for cutaneous antisepsis. Cultures were taken at the site surrounding catheter insertion and at the catheter hub after removal to help identify the source of microorganisms. <sec id="st1"><title>Results:</title><p> Catheter related sepsis was 10.5&#x0025; in the povidone iodine and octenidine hydrochlorodine groups. Catheter related colonization was 26.3&#x0025; in povidone iodine group and 21.5&#x0025; in octenidine hydrochlorodine group. <sec id="st1"><title>Conclusion:</title><p> 4&#x0025; chlorhexidine or octenidine hydrochlorodine for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can reduce the catheter related colonization.</p>
</sec>
<sec id="st2"><title>Materials and Methods:</title><p> Patients were randomized to receive; 4&#x0025; chlorhexidine gluconate, 10&#x0025; povidone iodine or octenidine hydrochlorodine for cutaneous antisepsis. Cultures were taken at the site surrounding catheter insertion and at the catheter hub after removal to help identify the source of microorganisms. <sec id="st2"><title>Results:</title><p> Catheter related sepsis was 10.5&#x0025; in the povidone iodine and octenidine hydrochlorodine groups. Catheter related colonization was 26.3&#x0025; in povidone iodine group and 21.5&#x0025; in octenidine hydrochlorodine group. <sec id="st2"><title>Conclusion:</title><p> 4&#x0025; chlorhexidine or octenidine hydrochlorodine for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can reduce the catheter related colonization.</p>
</sec>
<sec id="st3"><title>Results:</title><p> Catheter related sepsis was 10.5&#x0025; in the povidone iodine and octenidine hydrochlorodine groups. Catheter related colonization was 26.3&#x0025; in povidone iodine group and 21.5&#x0025; in octenidine hydrochlorodine group. <sec id="st3"><title>Conclusion:</title><p> 4&#x0025; chlorhexidine or octenidine hydrochlorodine for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can reduce the catheter related colonization.</p>
</sec>
<sec id="st4"><title>Conclusion:</title><p> 4&#x0025; chlorhexidine or octenidine hydrochlorodine for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can reduce the catheter related colonization.</p>
</sec>
</abstract>
      <kwd-group><kwd>Catheter infection</kwd>
<kwd>chlorhexidine</kwd>
<kwd>cutaneous</kwd>
<kwd>octenidine hydrochlorodine</kwd>
<kwd>povidone iodine</kwd>
</kwd-group>	
      
    </article-meta>
  </front>
  <body>
	<sec><title/>
</sec><sec><title>Introduction</title><p>As progress in critical care has advanced, medical technology has led to the creation of many intravascular devices for the purpose of fluid and drug administration, hemodynamic monitoring, hemodialysis and other functions that have greatly improved our ability to deliver care to critically ill patients. Although such catheters provide necessary vascular access, the use of these catheters puts patients at risk for complications such as local site infection, catheter-related bloodstream infection, septic trombophlebitis, endocarditis and metastatic infections (e.g., lung abscess, brain abscess, osteomyelitis and endophthalmitis). <sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Furthermore, these conditions contribute to increased morbidity, mortality, length of stay and excessive cost of care. <sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Because nosocomial infection rates become more frequently included in the criteria used for assessing the quality of patient care, implementation of prevention strategies becomes more important.</p>

<p>Protection of the catheter site by antimicrobial agents is one of the most important factors in the prevention of infection. Appropriate sterile dressings should cover the insertion site and be replaced on a regular basis. <sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Povidone iodine, chlorhexidine gluconate and octenidine hydrochloride are the most common used agents for dressing. The purpose of this study is to compare the effects of povidone iodine, chlorhexidine gluconate and octenidine hydrochloride in preventing catheter related infections.</p>


</sec><sec sec-type='materials|methods'><title>Materials and Methods</title><p>The study was performed in anesthesiology and reanimation intensive care unit (ICU) of Eskisehir Osmangazi University Medical Faculty. After approval from the hospital ethics and research committee, written permissions were obtained either from the patients themselves or from the legal surrogate. Fifty seven patients requiring intravascular catheterization were included in this trial. Completed data could be evaluated for 109 catheters from these patients (57 arterial catheters and 52 central venous catheters). By use of a blinded randomization schedule, we assigned to each patient to 1 of 3 groups according to the antiseptic solution used for initial and subsequent cutaneous antisepsis. The catheter data collected included location, insertion date, duration and site inspection. Additional patient data collected included age, sex, duration in ICU, underlying medical problems, treatment with steroids or antibiotics, temperature and clinical outcome.</p>

<p>Patients were randomized to receive 4&#x0025; chlorhexidine gluconate (Group I, n = 19), 10&#x0025; povidone iodine (Group II, n = 19) or octenidine hydrochlorodine (Group III, n = 19) for cutaneous antisepsis. The skin was cleaned by designed antiseptic solution before the insertion of the catheter and the same antiseptic solution used for the following days. The insertion site and dressings were inspected daily by patient&#x2032;s physician to search for signs of infection, inflammation or cutaneous allergic events to the disinfectants. Cultures were taken at the site surrounding catheter insertion daily and at the catheter hub after removal to help identify the source of microorganisms. Standard microbiologic methods and criteria identified recovered microorganisms. The laboratory technicians were unaware of the antiseptic solution used for skin preparation. Colonization of the catheter was related to the skin when the same bacterial isolate yielded from the catheter and the skin surrounding the insertion site.</p>

<p> Statistical analysis</p>

<p> All statistical analyses were performed using the SPSS for windows 13.0. Data are expressed as medians for characteristics of the patients and catheters or percentages for categorical variables. Data were analyzed for differences between the study groups by one-way anova and Bonferroni&#x2032;s post-hoc test. A P value of &lt;0.05 was considered statistically significant.</p>


</sec><sec><title>Results</title><p>A total of 57 patients requiring intravascular catheterization were included in this trial. Completed data could be evaluated for 109 catheters from these patients (57 arterial catheters and 52 central venous catheters). There were no significant differences between groups in demographic characteristics <xref ref-type="table" rid="T1">Table 1</xref>. The clinical characteristics of patients and the risk factors for infection were similar in the two groups. Neither local nor systemic hypersensitivity reactions were observed with the use of either antiseptic solution. Catheters were kept in place for 7.2 days in Group I, 7.8 days in Group II and 7.5 days in Group III.{Table 1}</p>

<p>There was a statistically significant difference between groups in catheter related sepsis and colonization (P &lt; 0.001). Documented catheter related sepsis rate was 10.5&#x0025; in the povidone iodine and octenidine hydrochlorodine groups. Catheter related colonization rate was 26.3&#x0025; in povidone iodine group and 21.5&#x0025; in octenidine hydrochlorodine group. In chlorhexidine group, there was no catheter related sepsis or colonization <xref ref-type="table" rid="T2">Table 2</xref>.{Table 2}</p>

<p>The only bacterial species isolated was Acinetobacter calcoaceticus (100&#x0025;) in catheter related sepsis A. calcoaceticus (80&#x0025;) and Enterococcus fecalis (20&#x0025;) were the colonizing microorganisms. The skin surrounding the catheter insertion site was the origin of the colonizing microorganisms.</p>


</sec><sec><title>Discussion</title><p>Regardless of the type of catheter inserted, the major risk factor for the development of catheter related infection is the breach of a major host defense against infection, the skin. <sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Migration of skin organisms at the insertion site in to the cutaneous catheter tract with colonization is the most common route of infection. Skin flora introduced either at the time of puncture or a result of bacterial migration along a catheter or needle tract has been implicated as a potential source of infection. Aseptic technique at the time of insertion and during access of the intravascular device is important in reducing the risk of infection. Many different methods have been used in an attempt to reduce microbial contamination at the insertion site of catheter.</p>

<p>Povidone iodine and chlorhexidine gluconate are the most common used agents for dressing. Octenidine hydrocloride is a byspyridine skin and wound disinfectant. It is a compound that is active on cell walls due to its cationic properties. <sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Our study demonstrates that use of 4&#x0025; chlorhexidine rather than 10&#x0025; Povidone iodine or octenidine hydrochlorodine for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can substantially reduce the incidence of device-related infection. This finding is consistent previous reports. <sup><xref ref-type="bibr" rid="ref6">6</xref></sup>,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup>,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup>,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup>,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Maki et al. concluded that use of 2&#x0025; chlorhexidine, rather than 10&#x0025; Povidone-iodine or 70&#x0025; alcohol for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can reduce incidence of infection. <sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Likewise, Mimoz et al. demonstrated that 4&#x0025; alcohol-based solution of 0.25&#x0025; chlorhexidine gluconate was more effective than 10&#x0025; Povidone iodine for insertion site care of central venous and arterial catheters. <sup><xref ref-type="bibr" rid="ref12">12</xref></sup> Chlorhexidine gluconate is a potent broad-spectrum germicide and it is effective against nearly all nosocomial bacteria and yeasts. <sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Superior performance of chlorhexidine is explained by its more potent bactericidal activity and its high permeability in to the hair follicules. <sup><xref ref-type="bibr" rid="ref14">14</xref></sup> And the success of this agent might also be attributable to antimicrobial activity that persists longer than that for the other agents. <sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Our study supports these findings.</p>

<p>But also there are some studies, which are not in accordance with these conclusions. Kasuda et al. demonstrated that the effect of 0.5&#x0025; chlorhexidine ethanol is not different from that of 10&#x0025; Povidone iodine in reducing catheter colonization. <sup><xref ref-type="bibr" rid="ref15">15</xref></sup> In a randomized trial comparing Povidone-iodine to a chlorhexidine gluconate impregnated dressing for prevention of central venous catheter infections in neonates that there is no difference in the efficiency of two antiseptic solutions. <sup><xref ref-type="bibr" rid="ref16">16</xref></sup> In a prospective randomized trial of 10&#x0025; Povidone-iodine versus 0.5&#x0025; tincture of chlorhexidine as a cutaneous antisepsis, Humar et al. concluded that there was no difference between two antiseptic solutions. <sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p>

<p> Coagulase-negative staphylococci (including Staphylococcus epidermidis and other species) are most commonly implicated in catheter related infections, followed by Staphylococcus aureus, a variety of aerobic gram-negative bacilli, other gram-positive cocci and bacilli and Candida and other yeasts. <sup><xref ref-type="bibr" rid="ref4">4</xref></sup>,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup>,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> In our study, A. calcoaceticus was the most common microorganism in catheter related sepsis and colonization. The superiority may be explained by the flora of our ICU and hospital during the study period. Catheter colonization can arise from clinicians&#x2032; and nurses&#x2032; handling of syringes and solutions.</p>

<p>There were some limitations of our study. The first one was the number of patients. The larger number of patients may give more details about the effect of agents on different microorganisms. The second one was that the physicians were not blinded because of the difference in the color of the antiseptic solutions. The third limitation was the different duration of the patients in the ICU; although, there was no significant difference between the durations of the groups. Longer duration will increase the incidence of catheter related infections. And the last one was that it was not the same clinician who is responsible of catheter care.</p>


</sec><sec><title>Conclusion</title><p>Chlorhexidine is an effective disinfectant agent in adult ICU. The use of 4&#x0025; chlorhexidine rather than 10&#x0025; povidone iodine or octenidine hydrochlorodine for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can substantially reduce the incidence of catheter related infection.</p>
</sec>
  </body>
  <back>
	
	
	    <ref-list><ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>O&#x2032;Grady</surname>
  <given-names>NP</given-names>
</name>
</person-group><article-title>Applying the science to the prevention of catheter-related infections</article-title><source>J Crit Care</source>
<year>2002</year>
<volume>17</volume>
<fpage>114</fpage>
<lpage>21</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Dixon</surname>
  <given-names>JM</given-names>
</name>
<name> 
  <surname>Carver</surname>
  <given-names>RL</given-names>
</name>
</person-group><article-title>Daily chlorohexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections</article-title><source>Am J Infect Control</source>
<year>2010</year>
<volume>38</volume>
<fpage>817</fpage>
<lpage>21</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author"><name> 
  <surname>Sanders</surname>
  <given-names>WM</given-names>
</name>
</person-group><article-title>Critical Care</article-title><source></source>
<publisher-loc>McGraw-Hill</publisher-loc><publisher-name>United States of America</publisher-name>
<year>1996</year>
<volume></volume>
<fpage>483</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author"><name> 
  <surname>Bradley</surname>
  <given-names>SF</given-names>
</name>
<name> 
  <surname>Kaufmann</surname>
  <given-names>CA</given-names>
</name>
</person-group><article-title>Intensive Care Medicine</article-title><source></source>
<publisher-loc>Little Brown and Company</publisher-loc><publisher-name>United States of America</publisher-name>
<year>1996</year>
<volume></volume>
<fpage>1141</fpage>
<lpage>52</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Harke</surname>
  <given-names>HP</given-names>
</name>
</person-group><article-title>Octenidine dihydrochloride, properties of a new antimicrobial agent</article-title><source>Zentralbl Hyg Umweltmed</source>
<year>1989</year>
<volume>188</volume>
<fpage>188</fpage>
<lpage>93</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Maki</surname>
  <given-names>DG</given-names>
</name>
<name> 
  <surname>Ringer</surname>
  <given-names>M</given-names>
</name>
<name> 
  <surname>Alvarado</surname>
  <given-names>CJ</given-names>
</name>
</person-group><article-title>Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters</article-title><source>Lancet</source>
<year>1991</year>
<volume>338</volume>
<fpage>339</fpage>
<lpage>43</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Chaiyakunapruk</surname>
  <given-names>N</given-names>
</name>
<name> 
  <surname>Veenstra</surname>
  <given-names>DL</given-names>
</name>
<name> 
  <surname>Lipsky</surname>
  <given-names>BA</given-names>
</name>
<name> 
  <surname>Sullivan</surname>
  <given-names>SD</given-names>
</name>
<name> 
  <surname>Saint</surname>
  <given-names>S</given-names>
</name>
</person-group><article-title>Vascular catheter site care: The clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine</article-title><source>Clin Infect Dis</source>
<year>2003</year>
<volume>37</volume>
<fpage>764</fpage>
<lpage>71</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Krau</surname>
  <given-names>SD</given-names>
</name>
</person-group><article-title>Review: Chlorhexidine gluconate is more effective than povidone-iodine for preventing vascular catheter related bloodstream infection</article-title><source>Evid Based Nurs</source>
<year>2003</year>
<volume>6</volume>
<fpage>18</fpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Chaiyakunapruk</surname>
  <given-names>N</given-names>
</name>
<name> 
  <surname>Veenstra</surname>
  <given-names>DL</given-names>
</name>
<name> 
  <surname>Lipsky</surname>
  <given-names>BA</given-names>
</name>
<name> 
  <surname>Saint</surname>
  <given-names>S</given-names>
</name>
</person-group><article-title>Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis</article-title><source>Ann Intern Med</source>
<year>2002</year>
<volume>136</volume>
<fpage>792</fpage>
<lpage>801</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Mimoz</surname>
  <given-names>O</given-names>
</name>
<name> 
  <surname>Karim</surname>
  <given-names>A</given-names>
</name>
<name> 
  <surname>Mercat</surname>
  <given-names>A</given-names>
</name>
<name> 
  <surname>Cosseron</surname>
  <given-names>M</given-names>
</name>
<name> 
  <surname>Falissard</surname>
  <given-names>B</given-names>
</name>
<name> 
  <surname>Parker</surname>
  <given-names>F</given-names>
</name>
 <etal/>
</person-group><article-title>Chlorhexidine compared with povidone-iodine as skin preparation before blood culture.A randomized, controlled trial</article-title><source>Ann Intern Med</source>
<year>1999</year>
<volume>131</volume>
<fpage>834</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Carson</surname>
  <given-names>SM</given-names>
</name>
</person-group><article-title>Chlorhexidine versus povidone-iodine for central venous catheter site care in children</article-title><source>J Pediatr Nurs</source>
<year>2004</year>
<volume>19</volume>
<fpage>74</fpage>
<lpage>80</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Mimoz</surname>
  <given-names>O</given-names>
</name>
<name> 
  <surname>Pieroni</surname>
  <given-names>L</given-names>
</name>
<name> 
  <surname>Lawrence</surname>
  <given-names>C</given-names>
</name>
<name> 
  <surname>Edouard</surname>
  <given-names>A</given-names>
</name>
<name> 
  <surname>Costa</surname>
  <given-names>Y</given-names>
</name>
<name> 
  <surname>Samii</surname>
  <given-names>K</given-names>
</name>
 <etal/>
</person-group><article-title>Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients</article-title><source>Crit Care Med</source>
<year>1996</year>
<volume>24</volume>
<fpage>1818</fpage>
<lpage>23</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Rubin</surname>
  <given-names>C</given-names>
</name>
<name> 
  <surname>Louthan</surname>
  <given-names>RB</given-names>
</name>
<name> 
  <surname>Wessels</surname>
  <given-names>E</given-names>
</name>
<name> 
  <surname>McGowan</surname>
  <given-names>MB</given-names>
</name>
<name> 
  <surname>Downer</surname>
  <given-names>S</given-names>
</name>
<name> 
  <surname>Maiden</surname>
  <given-names>J</given-names>
</name>
</person-group><article-title>Chlorhexidine gluconate: To bathe or not to bathe&#x003F;</article-title><source>Crit Care Nurs Q</source>
<year>2013</year>
<volume>36</volume>
<fpage>233</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref14">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Kinirons</surname>
  <given-names>B</given-names>
</name>
<name> 
  <surname>Mimoz</surname>
  <given-names>O</given-names>
</name>
<name> 
  <surname>Lafendi</surname>
  <given-names>L</given-names>
</name>
<name> 
  <surname>Naas</surname>
  <given-names>T</given-names>
</name>
<name> 
  <surname>Meunier</surname>
  <given-names>J</given-names>
</name>
<name> 
  <surname>Nordmann</surname>
  <given-names>P</given-names>
</name>
</person-group><article-title>Chlorhexidine versus povidone iodine in preventing colonization of continuous epidural catheters in children: A randomized, controlled trial</article-title><source>Anesthesiology</source>
<year>2001</year>
<volume>94</volume>
<fpage>239</fpage>
<lpage>44</lpage>
</nlm-citation>
</ref>
<ref id="ref15">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Kasuda</surname>
  <given-names>H</given-names>
</name>
<name> 
  <surname>Fukuda</surname>
  <given-names>H</given-names>
</name>
<name> 
  <surname>Togashi</surname>
  <given-names>H</given-names>
</name>
<name> 
  <surname>Hotta</surname>
  <given-names>K</given-names>
</name>
<name> 
  <surname>Hirai</surname>
  <given-names>Y</given-names>
</name>
<name> 
  <surname>Hayashi</surname>
  <given-names>M</given-names>
</name>
</person-group><article-title>Skin disinfection before epidural catheterization: Comparative study of povidone-iodine versus chlorhexidine ethanol</article-title><source>Dermatology</source>
<year>2002</year>
<volume>204 (Suppl 1)</volume>
<fpage>42</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref16">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Garland</surname>
  <given-names>JS</given-names>
</name>
<name> 
  <surname>Alex</surname>
  <given-names>CP</given-names>
</name>
<name> 
  <surname>Mueller</surname>
  <given-names>CD</given-names>
</name>
<name> 
  <surname>Otten</surname>
  <given-names>D</given-names>
</name>
<name> 
  <surname>Shivpuri</surname>
  <given-names>C</given-names>
</name>
<name> 
  <surname>Harris</surname>
  <given-names>MC</given-names>
</name>
 <etal/>
</person-group><article-title>A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates</article-title><source>Pediatrics</source>
<year>2001</year>
<volume>107</volume>
<fpage>1431</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref17">
<label>17</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Humar</surname>
  <given-names>A</given-names>
</name>
<name> 
  <surname>Ostromecki</surname>
  <given-names>A</given-names>
</name>
<name> 
  <surname>Direnfeld</surname>
  <given-names>J</given-names>
</name>
<name> 
  <surname>Marshall</surname>
  <given-names>JC</given-names>
</name>
<name> 
  <surname>Lazar</surname>
  <given-names>N</given-names>
</name>
<name> 
  <surname>Houston</surname>
  <given-names>PC</given-names>
</name>
 <etal/>
</person-group><article-title>Prospective randomized trial of 10&#x0025; povidone-iodine versus 0.5&#x0025; tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection</article-title><source>Clin Infect Dis</source>
<year>2000</year>
<volume>31</volume>
<fpage>1001</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref18">
<label>18</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Sherertz</surname>
  <given-names>RJ</given-names>
</name>
<name> 
  <surname>Raad</surname>
  <given-names>II</given-names>
</name>
<name> 
  <surname>Belani</surname>
  <given-names>A</given-names>
</name>
<name> 
  <surname>Koo</surname>
  <given-names>LC</given-names>
</name>
<name> 
  <surname>Rand</surname>
  <given-names>KH</given-names>
</name>
<name> 
  <surname>Pickett</surname>
  <given-names>DL</given-names>
</name>
 <etal/>
</person-group><article-title>Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory</article-title><source>J Clin Microbiol</source>
<year>1990</year>
<volume>28</volume>
<fpage>76</fpage>
<lpage>82</lpage>
</nlm-citation>
</ref>
<ref id="ref19">
<label>19</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"><name> 
  <surname>Li&#241;ares</surname>
  <given-names>J</given-names>
</name>
<name> 
  <surname>Sitges-Serra</surname>
  <given-names>A</given-names>
</name>
<name> 
  <surname>Garau</surname>
  <given-names>J</given-names>
</name>
<name> 
  <surname>P&#233;rez</surname>
  <given-names>JL</given-names>
</name>
<name> 
  <surname>Mart&#237;n</surname>
  <given-names>R</given-names>
</name>
</person-group><article-title>Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segments</article-title><source>J Clin Microbiol</source>
<year>1985</year>
<volume>21</volume>
<fpage>357</fpage>
<lpage>60</lpage>
</nlm-citation>
</ref>
<ref id="ref20">
<label>20</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author"></person-group><article-title></article-title><source></source>
<year></year>
<volume></volume>
<fpage></fpage>
</nlm-citation>
</ref>
</ref-list>

  </back>
	
</article> 




